Roots Analysis

Roots Analysis provide business research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters:

•Technology evolution
•Research and development
•Existing market landscape
•Future Commercial potential
•Regulatory concerns
•Regional growth drivers
•Risks and opportunities

Roots Analysis

List of reports from Roots Analysis

< prev 1    
3D Cell Culture Market 2015-2025
5/28/2015 | published by: Roots Analysis
... are useful for studying the basic human molecular and cell biology metabolisms. Cell culturing was first initiated in flat plastic or glass dishes as 2D cell culturing. Since then, all the tissue engineering, stem cell, ...  |  read more...
USD 2,199
Sustained Release Ocular Drug Delivery Systems, 2015 - 2025 (2nd edition)
5/25/2015 | published by: Roots Analysis
... specific ocular site. Several barriers have to be overcome for a successful ocular drug delivery. These include dilution of a drug by tears, clearance of a drug by the lymphatic system of conjunctiva and drug ...  |  read more...
USD 2,199
Blood Brain Barrier Technologies: Novel CNS Drug Delivery Approaches’
5/12/2015 | published by: Roots Analysis
... not treat the root cause. This is because of their inability to penetrate across the blood brain barrier (BBB). BBB is a highly selective permeable membrane which allows the entry of only specific molecules, across ...  |  read more...
USD 2,199
Biopharmaceutical Contract Manufacturing Market, 2015 - 2025
5/5/2015 | published by: Roots Analysis
... to serving as a cost-cutting tool, contract manufacturing provides several other advantages to biopharmaceutical companies including technical expertise, operational efficiency, regulatory support and the ability to focus on core competencies. Spanning multiple operations within the ...  |  read more...
USD 2,199
Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025
4/24/2015 | published by: Roots Analysis
... many pharmaceutical companies to improve these treatments as well as discover novel cancer therapies with minimum toxic effects. Targeted cancer therapy is an upcoming area gaining strong foothold in the industry and has already become ...  |  read more...
USD 2,199
Contract Manufacturing in Pharmaceutical Industry, 2015-2025
2/25/2015 | published by: Roots Analysis
... a network of suppliers. As such, contract manufacturing has evolved as one of the integral components of the pharmaceutical market. Started initially as a one-off activity, contract manufacturing has evolved into a dynamic business model; ...  |  read more...
USD 2,199
Gene Therapy Market, 2015 - 2025
2/25/2015 | published by: Roots Analysis
... or delete the genes causing a particular disease is known as gene therapy. Although gene therapy has not contributed significantly to the global pharmaceutical market yet, it is anticipated to grow at a fast pace ...  |  read more...
USD 2,199
Oral Proteins and Peptides Market (2nd Edition), 2015 – 2025
1/27/2015 | published by: Roots Analysis
... delivery is the more preferred route. Although very convenient, there are many challenges which hinder this route of administration. These include enzymatic and pH-dependent degradation of the amino acid based drugs in the gastrointestinal tract, ...  |  read more...
USD 1,899
Subcutaneous Biologics: Products, Technologies and Delivery Systems
1/12/2015 | published by: Roots Analysis
... patient friendly format. Owing to its numerous compelling advantages, the concept has gained huge traction in recent years. The flexibility and convenience of subcutaneous administration over other routes of delivery, along with the increasing trend ...  |  read more...
USD 1,899
Oral Thin Films Market, 2015 - 2025
1/12/2015 | published by: Roots Analysis
... / films, the market has come a long way. Lower bioavailability of oral solid drugs, inconvenience of administering injections, inaccurate dosing by liquid formulations have turned the focus of pharmaceutical companies to develop novel oral ...  |  read more...
USD 1,899
Bispecific Antibody Therapeutics Market (2nd Edition), 2014-2024
12/2/2014 | published by: Roots Analysis
... the monoclonal antibody based therapies.Bispecific antibodies are artificial antibodies created by joining together two monoclonal antibodies (or parts) that target different epitopes. The resulting antibody has binding affinities for two or three different epitopes concurrently. ...  |  read more...
USD 1,899
Novel Drug Reconstitution Systems Market, 2014-2024
12/2/2014 | published by: Roots Analysis
... by various processes such as lyophilisation or spray drying; these drugs are then reformulated into liquid form by mixing with a suitable diluent at the time of administration. The overall market of drug reconstitution systems ...  |  read more...
USD 1,899
Dendritic Cell and CAR-T Therapies Market, 2014-2024
11/20/2014 | published by: Roots Analysis
... / orphan forms. Although oncology continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug developers is gradually moving towards ...  |  read more...
USD 1,899
Inner Ear Diseases: Novel Drug Delivery Approaches, 2014 - 2025
11/5/2014 | published by: Roots Analysis
... in the market. The current treatment of inner ear diseases is primarily based on counselling, electric and magnetic nerve stimulations. At the same time, there is a growing off-label use of drugs for symptomatic relief. ...  |  read more...
USD 1,899
Microneedles for Transdermal and Intradermal Drug Delivery, 2014-2030
10/29/2014 | published by: Roots Analysis
... size, capable of creating transient pores across the skin by penetrating the stratum corneum layer to deliver molecules. These needles are not big enough to reach the nerve-rich regions of the skin; as a result, ...  |  read more...
USD 1,899
Immune Checkpoint Inhibitors Market, 2014-2024
10/11/2014 | published by: Roots Analysis
... forms. Although cancer therapeutics continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug developers is gradually moving towards immunotherapeutics, ...  |  read more...
USD 1,899
Needlestick Safety Injection Devices Market, 2014 - 2024
10/8/2014 | published by: Roots Analysis
... and healthcare professionals worldwide. The accelerated emergence of regulatory controls over the past few years have further ensured that manufacturers come up with modifications in the product design and integrated safety controls to meet the ...  |  read more...
USD 1,899
PCSK9 and Other Novel Hypercholesterolemia Drugs Market, 2014 - 2024
9/5/2014 | published by: Roots Analysis
... available options, statins have been ubiquitously prescribed over the last 25 years. Researchers have concluded that reduction of plasma LDL cholesterol (LDLC) is the cornerstone of assessing heart risk. Irrespective of baseline cholesterol concentration, each ...  |  read more...
USD 1,899
Large Volume Wearable Injectors (2nd Edition), 2014-2025
9/1/2014 | published by: Roots Analysis
... has come a long way. The rising prevalence of chronic diseases is one of the key factors driving the companies to develop systems that allow patients to self-administer drugs. Taking the concept of self-injectors to ...  |  read more...
USD 1,899
Glycated Haemoglobin (HbA1c) Testing Market, 2014 - 2024
8/14/2014 | published by: Roots Analysis
... the number, though, is likely to increase to 592 million by 2035. With a very high prevalence, especially in some regions such as China and India, an increasing proportion of diabetic patients are expected to ...  |  read more...
USD 1,899
HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014 - 2024
8/6/2014 | published by: Roots Analysis
... The trend is likely to continue and the anti-cancer market will drive the growth of HPAPIs and cytotoxics in the future. 2. A good proportion of HPAPI / cytotoxics manufacturing is currently outsourced. In fact, ...  |  read more...
USD 1,899
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024
8/4/2014 | published by: Roots Analysis
... more than USD 600 million in 2014. 2. About 45 molecules are currently in clinical development. Of these, approximately 25% are in Phase II or Phase III of development. As expected, the preclinical pipeline is ...  |  read more...
USD 1,899
Prefilled Syringes Market (2nd Edition), 2014 - 2024
7/15/2014 | published by: Roots Analysis
... 2024, we expect the market to achieve sales of around 12.4 billion prefilled syringes. 2. Vaccines, diluent and flush syringes are likely to be some of the key growth areas. The emergence of biologics will ...  |  read more...
USD 1,899
Pharmaceutical Spray Drying Market, 2014 - 2024
6/24/2014 | published by: Roots Analysis
... These include Intelence, Kalydeco, Incivek, and Zortress. 2. Specific to the pharmaceutical industry, there are around 50 models of spray dryers which are currently available worldwide. These models offer variation in the scale of operation ...  |  read more...
USD 1,899
Diagnostics: Companion Diagnostics Market (2nd Edition), 2014-2024
6/5/2014 | published by: Roots Analysis
... of companion diagnostics holds huge potential for pharma companies as well as medical community. This new approach to medication is expected to transform healthcare by improving treatment outcomes, eliminating adverse reactions and reducing cost and ...  |  read more...
USD 1,899
< prev 1    
US: 800.298.5699
Int'l: +1.240.747.3093
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!